vTv Therapeutics
VTVT
44 hedge funds and large institutions have $4.94M invested in vTv Therapeutics in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 9 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 7
56% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 9
13% more funds holding
Funds holding: 39 → 44 (+5)
0.09% less ownership
Funds ownership: 0.21% → 0.12% (-0.09%)
31% less capital invested
Capital invested by funds: $7.14M → $4.94M (-$2.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$361K |
| 2 |
Renaissance Technologies
New York
|
+$145K |
| 3 |
BlackRock
New York
|
+$128K |
| 4 |
VF
Virtu Financial
New York
|
+$72.2K |
| 5 |
EGM
Engineers Gate Manager
New York
|
+$66.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Frazier Management
Seattle,
Washington
|
-$1.88M |
| 2 |
Two Sigma Investments
New York
|
-$889K |
| 3 |
Two Sigma Advisers
New York
|
-$829K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$131K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$68K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
AllianceBernstein
Nashville,
Tennessee
| – | -$19K | -265 | Closed |
|
|
GWM
52
Geneos Wealth Management
Englewood,
Colorado
| – | -$1K | -25 | Closed |
|
|
IAIM
53
International Assets Investment Management
Orlando,
Florida
| – | +$230 | +3 | New |
|
VTVT Hedge Fund Activity: Q4 2020 in Review
44 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q4 2020, worth a combined $4.94M — down 31% from $7.14M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new VTVT positions and 9 closed out — a net gain of 5 holders — while 14 added to existing stakes and 7 trimmed.
The largest buyer was Ensign Peak Advisors, opening a new position worth an estimated $361K. The largest seller was Frazier Management, exiting entirely with an estimated $1.88M sold.
- 44 institutional investors held vTv Therapeutics (VTVT) as of Q4 2020, up from 39 in Q3 2020.
- Funds reported $4.94M of vTv Therapeutics stock for Q4 2020, down 31% quarter-over-quarter.
- 14 funds opened new vTv Therapeutics positions in Q4 2020 and 9 closed out, a net change of +5 holders.
- The largest vTv Therapeutics buyer in Q4 2020 was Ensign Peak Advisors, an estimated $361K added.
- The largest vTv Therapeutics seller in Q4 2020 was Frazier Management, an estimated $1.88M sold.
Based on aggregated 13F filings for Q4 2020.